Which Parkinson disease therapy is well established as effective but tends to wear off with long-term use?

Prepare for the PANCE Neurology Test with comprehensive materials. Use flashcards and multiple-choice questions, each featuring hints and explanations. Boost your confidence and ace your exam!

Multiple Choice

Which Parkinson disease therapy is well established as effective but tends to wear off with long-term use?

Explanation:
Levodopa provides the greatest and most reliable improvement of motor symptoms in Parkinson disease because it replenishes brain dopamine by delivering a precursor that can cross into the brain and be converted to dopamine. Carbidopa boosts this effect by preventing peripheral breakdown, so more levodopa reaches the brain and side effects are reduced. This combination is well established as effective, but with long-term use the benefit often wears off before the next dose, and patients can experience dyskinesias at peak effect. The wearing-off arises from the progression of dopaminergic neuron loss and the pulsatile nature of oral levodopa, which leads to fluctuating motor control. Clinicians manage it by adjusting dosing intervals and sometimes adding other agents to smooth dopamine levels or using continuous delivery in advanced cases.

Levodopa provides the greatest and most reliable improvement of motor symptoms in Parkinson disease because it replenishes brain dopamine by delivering a precursor that can cross into the brain and be converted to dopamine. Carbidopa boosts this effect by preventing peripheral breakdown, so more levodopa reaches the brain and side effects are reduced. This combination is well established as effective, but with long-term use the benefit often wears off before the next dose, and patients can experience dyskinesias at peak effect. The wearing-off arises from the progression of dopaminergic neuron loss and the pulsatile nature of oral levodopa, which leads to fluctuating motor control. Clinicians manage it by adjusting dosing intervals and sometimes adding other agents to smooth dopamine levels or using continuous delivery in advanced cases.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy